We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of the Relationship Between Zinc Vitamin D and b12 Levels in the Covid-19 Positive Pregnant Women

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04407572
Recruitment Status : Completed
First Posted : May 29, 2020
Last Update Posted : June 23, 2020
Sponsor:
Collaborators:
Ayşegül Bestel
İbrahim Polat
Merve Aldıkaçtıoğlu Talmaç
Information provided by (Responsible Party):
Pınar Yalcin bahat, Kanuni Sultan Suleyman Training and Research Hospital

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Zinc d vitamin and b12 serum levels in covid-19 positive pregnants will be compared in terms of patients' responses to computed tomography and treatment.

Condition or disease Intervention/treatment
COVID Zinc Deficiency Vitamin D Deficiency Other: Serum zinc, vitamin d vitamin b12 levels .

Detailed Description:
Serum zinc, vitamin d vitamin b12 levels of 45 patients will be measured and evaluated together with the information of the patients.
Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Actual Enrollment : 44 participants
Observational Model: Case-Control
Time Perspective: Prospective
Official Title: Zinc Vitamin D and b12 Levels in the Covid-19 Positive Pregnant Women
Actual Study Start Date : April 20, 2020
Actual Primary Completion Date : June 1, 2020
Actual Study Completion Date : June 14, 2020

Resource links provided by the National Library of Medicine


Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Intervention Details:
  • Other: Serum zinc, vitamin d vitamin b12 levels .
    Serum zinc, vitamin d vitamin b12 levels of 45 patients will be measured and evaluated together with the information of the patients.

Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Serum zinc, vitamin d vitamin b12 deficiency levels [ Time Frame: 2 months ]
    Serum zinc, vitamin d vitamin b12 levels of 45 patients will be measured and evaluated together with the information of the patients.


Biospecimen Retention:   Samples Without DNA
Serum zinc, vitamin d vitamin b12 levels

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 45 Years   (Adult)
Sexes Eligible for Study:   Female
Gender Based Eligibility:   Yes
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Pregnant women between 18-45 years old with positive covid-19 pcr test results
Criteria

Inclusion Criteria:

  • covid-19 positive pregnant women
  • under 18 or more than 45 years old

Exclusion Criteria:

  • vitamin D , Vitamin B12 or Zinc supplement use
  • Multivitamine use
  • have taken vitamin supplements in the past 3 months
  • use of medicines for vitamin deficiency
  • having metabolic disease covid-19 negative pregnant women
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04407572


Locations
Layout table for location information
Turkey
Pinar Yalcin Bahat
Istanbul, İ̇stanbul, Turkey, 34000
Sponsors and Collaborators
Kanuni Sultan Suleyman Training and Research Hospital
Ayşegül Bestel
İbrahim Polat
Merve Aldıkaçtıoğlu Talmaç
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Pınar Yalcin bahat, Principal Investigator, Kanuni Sultan Suleyman Training and Research Hospital
ClinicalTrials.gov Identifier: NCT04407572    
Other Study ID Numbers: zinc-dvit-covid19
First Posted: May 29, 2020    Key Record Dates
Last Update Posted: June 23, 2020
Last Verified: June 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Vitamin D Deficiency
Avitaminosis
Deficiency Diseases
Malnutrition
Nutrition Disorders
Vitamin D
Vitamins
 Vitamin B 12
Hydroxocobalamin
Micronutrients
Physiological Effects of Drugs
Bone Density Conservation Agents
Vitamin B Complex
Hematinics